Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Hits Price Target Forecast with 18.52% Profit

April 25, 2024
ASTRAZENECA PLC, a leading pharmaceutical company, recently reached the price target forecast set by QuantWave with an impressive profit margin of 18.52%. The forecast signal was issued on November 21, 2023, when the stock was trading at 62.03 $. The predicted direction was long, and on April 25, 2024, ASTRAZENECA PLC reached the target price of 73.52 $.

This achievement highlights the accuracy and effectiveness of QuantWave's forecasting system in predicting stock movements. Market analysis indicates that various factors contributed to ASTRAZENECA PLC's price increase, including positive clinical trial results, successful drug launches, and overall growth in the pharmaceutical sector.

QuantWave, as an automated forecasting platform, offers users the opportunity to access predictions for a wide range of stocks, providing potential for profitable investments. For those interested in exploring investment strategies further, QuantSchool offers comprehensive educational resources on utilizing the QuantWave forecasting system to generate consistent income.

Overall, ASTRAZENECA PLC's successful price target forecast underlines the value and reliability of QuantWave's analytics for informed decision-making in the financial markets.

Find out how the ASTRAZENECA PLC rate is expected to change

Get Forecast for AZN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for AZN

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....



Related news

AZNAugust 15, 2024ASTRAZENECA PLC Stock Hits Price Target with 27.53% Profit - QuantWave Forecast Success  ~1 min.

ASTRAZENECA PLC stock has successfully reached its forecasted price target as predicted by QuantWave's automated forecasting platform. The forecast signal was generated on October 10, 2023, with a price of 65....

AZNMay 1, 2024ASTRAZENECA PLC Hits Price Target Forecast with 15.33% Profit, Showcasing the Accuracy of QuantWave's Analytics  ~2 min.

ASTRAZENECA PLC has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 15.33%. The forecast signal was given on January 16, 2024, with the stock priced at 64.92 $....

AZNJanuary 1, 2025Stocks Prognosis: Is AstraZeneca PLC AZN Set to Become a U.K. Dividend Champion by 2024?  ~2 min.

AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....

AZNFebruary 7, 2025AstraZeneca Plc Reports Strong Q4 2024 Earnings, Impressive Growth Prospects in the Pipeline  ~2 min.

AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....

AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....